相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study
Johanna W. M. Nin et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
High-Mobility Group Box Protein 1 Neutralization Reduces Development of Diet-Induced Atherosclerosis in Apolipoprotein E-Deficient Mice
Peter Kanellakis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Higher Plasma Levels of Advanced Glycation End Products Are Associated With Incident Cardiovascular Disease and All-Cause Mortality in Type 1 Diabetes A 12-year follow-up study
Johanna W. Nin et al.
DIABETES CARE (2011)
Increased serum high-mobility group box-1 and cleaved receptor for advanced glycation endproducts levels and decreased endogenous secretory receptor for advanced glycation endproducts levels in diabetic and non-diabetic patients with heart failure
Ling Jie Wang et al.
EUROPEAN JOURNAL OF HEART FAILURE (2011)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients
Xiao Xiang Yan et al.
ATHEROSCLEROSIS (2009)
Increased serum HMGB1 is related to the severity of coronary artery stenosis
Xiaorong Hu et al.
CLINICA CHIMICA ACTA (2009)
HMGB1 expression by activated vascular smooth muscle cells in advanced human atherosclerosis plaques
Katsumi Inoue et al.
CARDIOVASCULAR PATHOLOGY (2007)
Role of HMGB1 in cardiovascular diseases
W Li et al.
CURRENT OPINION IN PHARMACOLOGY (2006)
Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions - Role of activated macrophages and cytokines
N Kalinina et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
分享论文
